Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06717451 · ClinicalTrials.gov registry record

PS230005 Control-IQ 1.5 Post-Approval Study

A clinical trial of Type 1 Diabetes, sponsored by Tandem Diabetes Care.

Active
Registry status
144
Enrollment target
1
Study location

NCT06717451 is a study of Type 1 Diabetes that is active but no longer recruiting, run by Tandem Diabetes Care. The registered enrollment target is 144 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06717451, a study of Type 1 Diabetes, is active but no longer recruiting, sponsored by Tandem Diabetes Care.

ACTIVE NOT RECRUITING
Registry status
144 participants
Enrollment target
1
Study location

Study Summary

This 522 post-market surveillance study is a single-arm, decentralized prospective observational cohort study designed to collect safety data on Control-IQ technology v1.5 in children with type 1 diabetes ages 2 to \<6 years old. Participants will use Control-IQ technology v1.5 for 12 months in the real-world setting.

Conditions Studied

Type 1 Diabetes

Interventions

  • DEVICE Control-IQ Technology v1.5

Study Locations (1)

California

  • Tandem Diabetes Care - San Diego

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2025-01-30
Est. Completion 2026-08-11

Sponsor

Tandem Diabetes Care

13 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06717451

The ClinicalTrials.gov registry entry for NCT06717451 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (83% lower). The listed sponsor is Tandem Diabetes Care, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Control-IQ Technology v1.5 is the first listed.

NCT06717451 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06717451 about?

NCT06717451 is a clinical study titled "PS230005 Control-IQ 1.5 Post-Approval Study". This 522 post-market surveillance study is a single-arm, decentralized prospective observational cohort study designed to collect safety data on Control-IQ technology v1.5 in children with type 1 diabetes ages 2 to \<6 years old. Participants will use Control-IQ technology v1.5 for 12 months in the ...

What is the current status of trial NCT06717451?

This trial is currently active not recruiting. The enrollment target is 144 participants. The study started on 2025-01-30. Estimated completion is 2026-08-11.

What conditions does trial NCT06717451 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT06717451?

The interventions under investigation include: Control-IQ Technology v1.5 (DEVICE).

Who is sponsoring clinical trial NCT06717451?

This trial is sponsored by Tandem Diabetes Care, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06717451 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 1 Diabetes

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.